|
Cuenca-Zamora EJ, Guijarro-Carrillo PJ, Lopez-Poveda MJ, Morales ML, Lozano ML, Gonzalez-Conejero R, Martinez C, Teruel-Montoya R, Ferrer-Marin F. miR-146a-/- mice model reveals that NF-kappaB inhibition reverts inflammation-driven myelofibrosis-like phenotype. Am J Hematol. 2024 Jul;99(7):1326-1337. doi: 10.1002/ajh.27322. Epub 2024 Apr 22. PubMed PMID: 38646919.
AÑO: 2024; IF: 10.1
|
38646919
|
Aguila S, Gonzalez-Conejero R, Martinez C. microRNAs and thrombo-inflammation: relationship in sight. Curr Opin Hematol. 2024 May 1;31(3):140-147. doi: 10.1097/MOH.0000000000000803. Epub 2024 Jan 24. PubMed PMID: 38277182.
AÑO: 2024; IF: 3.1
|
|
Cuenca-Zamora EJ, Martinez C, Morales ML, Guijarro-Carrillo PJ, Lopez-Poveda MJ, Alcolea-Guardiola C, Vidal-Garrido N, Lozano ML, Gonzalez-Conejero R, Teruel-Montoya R, Ferrer-Marin F. Pacritinib prevents inflammation-driven myelofibrosis-like phenotype in a miR-146a-/- murine model. Biomed Pharmacother. 2024 Dec;181:117712. doi: 10.1016/j.biopha.2024.117712. Epub 2024 Nov 26. PubMed PMID: 39603040.
AÑO: 2024; IF: 6.9
|
|
Zapata-Martinez L, Aguila S, de Los Reyes-Garcia AM, Carrillo-Tornel S, Lozano ML, Gonzalez-Conejero R, Martinez C. Inflammatory microRNAs in cardiovascular pathology: another brick in the wall. Front Immunol. 2023 May 18;14:1196104. doi: 10.3389/fimmu.2023.1196104. eCollection 2023. PubMed PMID: 37275892; PubMed Central PMCID: PMC10233054.
AÑO: 2023; IF: 5.7
|
|
de Los Reyes-Garcia AM, Zapata-Martinez L, Aguila S, Lozano ML, Martinez C, Gonzalez-Conejero R. microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation. Front Cardiovasc Med. 2023 Feb 21;10:1135127. doi: 10.3389/fcvm.2023.1135127. eCollection 2023. PubMed PMID: 36895835; PubMed Central PMCID: PMC9988920.
AÑO: 2023; IF: 2.8
|